388 related articles for article (PubMed ID: 10352274)
1. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
Low PJ; Ai R; Ogata RT
J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
[TBL] [Abstract][Full Text] [Related]
2. Active sites in complement component C3 mapped by mutations at indels.
Ogata RT; Ai R; Low PJ
J Immunol; 1998 Nov; 161(9):4785-94. PubMed ID: 9794410
[TBL] [Abstract][Full Text] [Related]
3. Complement-inhibiting peptides identified by proximity to indels in the C3/4/5 protein family.
Ogata RT; Low PJ
J Immunol; 1997 Apr; 158(8):3852-60. PubMed ID: 9103453
[TBL] [Abstract][Full Text] [Related]
4. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
Sandoval A; Ai R; Ostresh JM; Ogata RT
J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
[TBL] [Abstract][Full Text] [Related]
5. Complement component C5: engineering of a mutant that is specifically cleaved by the C4-specific C1s protease.
Ogata RT; Low PJ
J Immunol; 1995 Sep; 155(5):2642-51. PubMed ID: 7650393
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase.
Ebanks RO; Isenman DE
J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
8. Substrate specificities of the protease of mouse serum Ra-reactive factor.
Ogata RT; Low PJ; Kawakami M
J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903
[TBL] [Abstract][Full Text] [Related]
9. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
[TBL] [Abstract][Full Text] [Related]
10. Third component of trout complement. cDNA cloning and conservation of functional sites.
Lambris JD; Lao Z; Pang J; Alsenz J
J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
13. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
Taniguchi-Sidle A; Isenman DE
J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
[TBL] [Abstract][Full Text] [Related]
14. Engineering of human complement component C3 for catalytic inhibition of complement.
Kölln J; Bredehorst R; Spillner E
Immunol Lett; 2005 Apr; 98(1):49-56. PubMed ID: 15790508
[TBL] [Abstract][Full Text] [Related]
15. Structural homologies of component C5 of human complement with components C3 and C4 by neutron scattering.
Perkins SJ; Smith KF; Nealis AS; Lachmann PJ; Harrison RA
Biochemistry; 1990 Feb; 29(5):175-80. PubMed ID: 2322569
[TBL] [Abstract][Full Text] [Related]
16. C3 requirements for formation of alternative pathway C5 convertase.
Daha MR; Fearon DT; Austen KF
J Immunol; 1976 Aug; 117(2):630-4. PubMed ID: 950465
[TBL] [Abstract][Full Text] [Related]
17. C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.
Volanakis JE
Year Immunol; 1989; 4():218-30. PubMed ID: 2648703
[No Abstract] [Full Text] [Related]
18. A cluster of positively charged amino acids in the alpha-chain of C4b-binding protein (C4BP) is pivotal for the regulation of the complement system and the interaction with bacteria.
Blom AM
Scand J Clin Lab Invest Suppl; 2000; 233():37-49. PubMed ID: 11317941
[TBL] [Abstract][Full Text] [Related]
19. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
Inal JM; Schifferli JA
J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
[TBL] [Abstract][Full Text] [Related]
20. Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy.
Stott B; Korbelik M
Cancer Immunol Immunother; 2007 May; 56(5):649-58. PubMed ID: 16947020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
